Topotecan Active Not Recruiting Phase 2 Trials for Lung Cancer Small Cell Lung Cancer (SCLC) / Small Cell Lung Cancer Extensive Stage / Small Cell Lung Cancer Limited Stage Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03059667Immunotherapy as Second-line in Patient With Small Cell Lung Cancer
NCT02963090Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer